Other
Haemnet
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
No phase data available
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT06064643Completed
The Lived Experience of People With Von Willebrand Disease
Role: lead
NCT04723693Completed
An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families
Role: lead
NCT05314751Completed
Learning to Live With Non-severe Haemophilia
Role: lead
NCT05315232Completed
The Experiences of People Who Live With Glanzmanns Thrombasthenia.
Role: lead
NCT04723680Completed
An Exploration of the Impact of Gene Therapy on the Lives of People With Haemophilia and Their Families
Role: lead
All 5 trials loaded